Osteoarthritis of the peripheral joints
IF Petersson, LTH Jacobsson - Best practice & research Clinical …, 2002 - Elsevier
Osteoarthritis (OA) is a complex process affecting many different joint areas in the body.
From a pathophysiological point of view some features are crucial for the diagnosis, such as …
From a pathophysiological point of view some features are crucial for the diagnosis, such as …
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
LTH Jacobsson, C Turesson, A Gülfe… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) in patients with
rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors, compared to a …
rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors, compared to a …
Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study.
S Bergman, PER Herrström, K Högström… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To estimate the prevalence of chronic regional and widespread
musculoskeletal pain in a sample of the general adult population and study the association …
musculoskeletal pain in a sample of the general adult population and study the association …
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year …
RF Van Vollenhoven, S Ernestam, P Geborek… - The Lancet, 2009 - thelancet.com
Background New treatment strategies for early rheumatoid arthritis are evolving rapidly. We
aimed to compare addition of conventional disease-modifying antirheumatic drugs …
aimed to compare addition of conventional disease-modifying antirheumatic drugs …
Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic …
IF Petersson, T Boegård, T Saxne, AJ Silman… - Annals of the …, 1997 - ard.bmj.com
OBJECTIVES To determine the prevalence of tibiofemoral radiographic knee osteoarthritis
(OA) in people aged 35–54 years associated with chronic (> 3 months) knee pain using two …
(OA) in people aged 35–54 years associated with chronic (> 3 months) knee pain using two …
[HTML][HTML] Current and future impact of osteoarthritis on health care: a population-based study with projections to year 2032
A Turkiewicz, IF Petersson, J Björk, G Hawker… - Osteoarthritis and …, 2014 - Elsevier
Objective To estimate the current and future (to year 2032) impact of osteoarthritis (OA)
health care seeking. Method Population-based study with prospectively ascertained data …
health care seeking. Method Population-based study with prospectively ascertained data …
Occurrence of osteoarthritis of the peripheral joints in European populations.
IF Petersson - Annals of the rheumatic diseases, 1996 - ncbi.nlm.nih.gov
The study of the occurrence of osteoarthritis, as well as other joint disorders, can be divided
into estimates of the incidence and of the prevalence. However, the studies of incidence …
into estimates of the incidence and of the prevalence. However, the studies of incidence …
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
P Geborek, A Bladström, C Turesson, A Gulfe… - Annals of the …, 2005 - ard.bmj.com
Objective: To determine whether TNF blockers increase tumour risk in patients with RA.
Material and methods: The South Swedish Arthritis Treatment Group register (SSATG) …
Material and methods: The South Swedish Arthritis Treatment Group register (SSATG) …
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded …
RF van Vollenhoven, P Geborek, K Forslind… - The Lancet, 2012 - thelancet.com
Summary Background Analysis of the Swedish Farmacotherapy (Swefot) trial at 12 months
showed that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical …
showed that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical …
Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study
AK Nilsdotter, IF Petersson, EM Roos… - Annals of the rheumatic …, 2003 - ard.bmj.com
Objectives: To investigate prospectively long term patient relevant outcomes after unilateral
total hip replacement (THR) for osteoarthritis (OA). To identify non-responders to this …
total hip replacement (THR) for osteoarthritis (OA). To identify non-responders to this …